Atazanavir Sulfate



Indications and Reactions:

Role Indications Reactions
Primary
Hiv Infection 75.6%
Antiretroviral Therapy 8.0%
Prophylaxis 3.4%
Lipodystrophy Acquired 3.1%
Drug Resistance 1.5%
Pneumonia 1.5%
Pneumonia Aspiration 1.1%
Hiv Test Positive 0.8%
Human Immunodeficiency Virus Transmission 0.8%
Hypersensitivity 0.8%
Migraine 0.8%
Acquired Immunodeficiency Syndrome 0.4%
Arthralgia 0.4%
Blood Cholesterol Increased 0.4%
Chronic Hepatic Failure 0.4%
Erectile Dysfunction 0.4%
Prophylaxis Against Hiv Infection 0.4%
Sinus Disorder 0.4%
Nephrolithiasis 13.6%
Pregnancy 11.4%
Renal Failure Acute 11.4%
Vomiting 9.1%
Ventricular Tachycardia 8.0%
Rhabdomyolysis 5.7%
Malaise 4.5%
Peripheral Vascular Disorder 4.5%
Skin Hyperpigmentation 4.5%
Blood Bilirubin Unconjugated Increased 3.4%
Diabetes Mellitus 3.4%
Calculus Ureteric 2.3%
Drug Abuse 2.3%
Gamma-glutamyltransferase Increased 2.3%
Glucose Tolerance Test Abnormal 2.3%
Jaundice 2.3%
Kaposi's Sarcoma 2.3%
Lipoma 2.3%
Nephritis Interstitial 2.3%
Pneumonia 2.3%
Secondary
Hiv Infection 52.8%
Drug Exposure During Pregnancy 14.2%
Drug Use For Unknown Indication 13.3%
Product Used For Unknown Indication 3.6%
Antiretroviral Therapy 2.4%
Acquired Immunodeficiency Syndrome 1.6%
Antifungal Prophylaxis 1.5%
Hepatitis C 1.3%
Diffuse Panbronchiolitis 1.3%
Systemic Antiviral Treatment 1.1%
Prophylaxis 1.1%
Maternal Exposure Timing Unspecified 1.0%
Haemophilia 0.8%
Hypertension 0.8%
Retroviral Infection 0.7%
Opportunistic Infection Prophylaxis 0.6%
Generalised Anxiety Disorder 0.5%
Hepatitis C Virus Test 0.5%
Tuberculosis 0.5%
Diabetes Mellitus 0.4%
Drug Exposure During Pregnancy 15.7%
Abortion Spontaneous 9.6%
Premature Baby 9.2%
Ultrasound Antenatal Screen Abnormal 8.7%
White Blood Cell Count Decreased 6.6%
Parkinsonism 4.8%
Hyperglycaemia 3.9%
Stillbirth 3.9%
Thrombocytopenia 3.9%
Ventricular Tachycardia 3.5%
Vomiting 3.5%
Hepatic Cirrhosis 3.1%
Lymphoma 3.1%
Nephrolithiasis 3.1%
Pancreatitis 3.1%
Rash 3.1%
Sepsis 3.1%
Weight Increased 3.1%
Muscle Injury 2.6%
Oesophageal Varices Haemorrhage 2.6%
Concomitant
Hiv Infection 56.9%
Drug Use For Unknown Indication 21.0%
Product Used For Unknown Indication 2.4%
Prophylaxis Against Hiv Infection 2.4%
Acquired Immunodeficiency Syndrome 2.1%
Hiv Test Positive 1.8%
Antiretroviral Therapy 1.7%
Antifungal Prophylaxis 1.2%
Depression 1.2%
Prophylaxis 1.1%
Drug Hypersensitivity 1.1%
Hypertension 1.0%
Headache 1.0%
Lymphoma Aids Related 0.9%
Opportunistic Infection Prophylaxis 0.9%
Hepatitis C 0.8%
Insomnia 0.7%
Castleman's Disease 0.7%
Rash 0.7%
Diabetes Mellitus 0.6%
Vomiting 13.0%
Abortion Spontaneous 11.4%
Death 8.1%
Premature Baby 4.9%
Weight Decreased 4.9%
Weight Increased 4.9%
Acrochordon 4.3%
Haemolytic Anaemia 4.3%
Somnambulism 4.3%
Transaminases Increased 4.3%
Pyrexia 3.8%
Renal Tubular Necrosis 3.8%
Suicidal Ideation 3.8%
Trisomy 21 3.8%
Ultrasound Antenatal Screen Abnormal 3.8%
Visual Disturbance 3.8%
Drug Exposure During Pregnancy 3.2%
Hepatitis Acute 3.2%
Peripheral Vascular Disorder 3.2%
Renal Failure Acute 3.2%
Interacting
Antiretroviral Therapy 29.6%
Hiv Infection 28.7%
Drug Use For Unknown Indication 20.9%
Schizoaffective Disorder 3.5%
Asthma 2.6%
Drug Dependence 2.6%
Liver Transplant 2.6%
Atrial Fibrillation 1.7%
Cholelithiasis 1.7%
Hiv Wasting Syndrome 1.7%
Ischaemic Cerebral Infarction 1.7%
Abnormal Behaviour 0.9%
Dyspepsia 0.9%
Mental Disorder 0.9%
Drug Interaction 16.0%
Drug Resistance 12.0%
Renal Failure 12.0%
Drug Level Increased 8.0%
Renal Failure Acute 8.0%
Rhabdomyolysis 8.0%
Kaposi's Sarcoma 4.0%
Kaposi's Sarcoma Aids Related 4.0%
Portal Vein Thrombosis 4.0%
Rib Fracture 4.0%
Sedation 4.0%
Sepsis 4.0%
Treatment Noncompliance 4.0%
Viral Load Increased 4.0%
Vomiting 4.0%